GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sawai Group Holdings Co Ltd (TSE:4887) » Definitions » Research & Development

Sawai Group Holdings Co (TSE:4887) Research & Development : 円13,609 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sawai Group Holdings Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sawai Group Holdings Co's Research & Development for the three months ended in Mar. 2024 was 円4,569 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was 円13,609 Mil.


Sawai Group Holdings Co Research & Development Historical Data

The historical data trend for Sawai Group Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sawai Group Holdings Co Research & Development Chart

Sawai Group Holdings Co Annual Data
Trend Mar22 Mar23 Mar24
Research & Development
24,413.00 16,090.00 12,189.00

Sawai Group Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,076.00 2,795.00 3,424.00 2,821.00 4,569.00

Sawai Group Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円13,609 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sawai Group Holdings Co  (TSE:4887) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Sawai Group Holdings Co Research & Development Related Terms

Thank you for viewing the detailed overview of Sawai Group Holdings Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Sawai Group Holdings Co (TSE:4887) Business Description

Traded in Other Exchanges
Address
5-2-30, Miyahara, Yodogawa-ku, Osaka, JPN, 532-0003
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.

Sawai Group Holdings Co (TSE:4887) Headlines

No Headlines